Yong Du

Yong Du

Auto-generated profile, based on publicly available information

Yong Du

Department of Epidemiology and Health Monitoring Robert Koch Institute Berlin Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2019 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
TTT. Tönnies
T. Tönnies
SRS. Röckl
S. Röckl
AHAnnika Hoyer
Annika Hoyer
CHC. Heidemann
C. Heidemann
JBJ. Baumert
J. Baumert
RBR. Brinks
R. Brinks

2 July 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YDYong Du
Yong Du
IWIngrid-Katharina Wolf
Ingrid-Katharina Wolf
WZWanli Zhuang
Wanli Zhuang
SBStefanie Bodemann
Stefanie Bodemann
WKWerner Knöss
Werner Knöss
HKHildtraud Knopf
Hildtraud Knopf
Germany is a country with a high use of herbal medicinal products. Population-based data on the use of herbal medicinal products among children are lacking. The aim of this study is to investigate the prevalence, patterns and determinants of herbal medicine use among children and adolescents in Germany.

1 July 2011 in European journal of pain
Verified
Journal Article
Closed access
YDYong Dul
Yong Dul
HKHildtraud Knopf
Hildtraud Knopf
WZWanli Zhuang
Wanli Zhuang
UEUte Ellert
Ute Ellert

23 February 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YDYong Du
Yong Du
CHChristin Heidemann
Christin Heidemann
AGAntje Gößwald
Antje Gößwald
PSPatrick Schmich
Patrick Schmich
CSChrista Scheidt-Nave
Christa Scheidt-Nave
Background: Despite the major public health impact of diabetes, recent population-based data regarding its prevalence and comorbidity are sparse. Methods: The prevalence and comorbidity of diabetes mellitus were analyzed in a nationally representative sample (N = 9133) of the non-institutionalized German adult population aged 50 years and older. Information on physician-diagnosed diabetes and 20 other chronic health conditions was collected as part of the national telephone health interview survey ‘German Health Update (GEDA)’ 2009. Overall, 51.2% of contacted persons participated. Among persons with diabetes, diabetes severity was defined according to the type and number of diabetes-concordant conditions: no diabetes-concordant condition (grade 1); hypertension and/or hyperlipidemia only (grade 2); one comorbidity likely to represent diabetes-related micro- or macrovascular end-organ damage (grade 3); several such comorbidities (grade 4). Determinants of diabetes severity were analyzed by multivariable ordinal regression. Results: The 12-month prevalence of diabetes was 13.6% with no significant difference between men and women. Persons with diabetes had a significantly higher prevalence and average number of diabetes-concordant as well as diabetes-discordant comorbidities than persons without diabetes. Among persons with diabetes, 10.2%, 46.8%, 35.6% and 7.4% were classified as having severity grade 1–4, respectively. Determinants of diabetes severity included age (cumulative odds ratio 1.05, 95% confidence interval 1.03-1.07, per year) and number of discordant comorbidities (1.40, 1.25-1.55). With respect to specific discordant comorbidities, diabetes severity was correlated to depression (2.15, 1.29-3.56), respiratory disease (2.75, 1.72-4.41), musculoskeletal disease (1.53, 1.06-2.21), and severe hearing impairment (3.00, 1.21-7.41). Conclusions: Diabetes is highly prevalent in the non-institutionalized German adult population 50 years and older. Diabetes comorbidities including diabetes-concordant and diabetes-discordant conditions need to be considered in epidemiological studies, in order to monitor disease burden and quality of diabetes care. Definitional standards of diabetes severity need to be refined and consented.

18 October 2007 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
YDYong Du
Yong Du
MDMartina Dören
Martina Dören
HMHans-Ulrich W Melchert
Hans-Ulrich W Melchert
CSChrista Scheidt-Nave
Christa Scheidt-Nave
HKHildtraud Knopf
Hildtraud Knopf
To examine the differences in menopausal hormone therapy (MHT) use and user profiles among women in Germany before and after the communication of the Women's Health Initiative (WHI) trial and other study results concerning the risks and benefits of MHT.

8 March 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JTJulia Truthmann
Julia Truthmann
ASAnja Schienkiewitz
Anja Schienkiewitz
MBMarkus A. Busch
Markus A. Busch
GMGert B. M. Mensink
Gert B. M. Mensink
YDYong Du
Yong Du
CSChrista Scheidt-Nave
Christa Scheidt-Nave
Monitoring of serum lipid concentrations at the population level is an important public health tool to describe progress in cardiovascular disease risk control and prevention. Using data from two nationally representative health surveys of adults 18–79 years, this study identified changes in mean serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in relation to changes in potential determinants of serum lipids between 1997–99 and 2008–11 in Germany. Sex-specific multivariable linear regression analyses were performed with serum lipids as dependent variables and survey wave as independent variable and adjusted for the following covariables: age, fasting duration, educational status, lifestyle, and use of medication. Mean TC declined between the two survey periods by 13 % (5.97 mmol/l vs. 5.19 mmol/l) among men and by 12 % (6.03 mmol/l vs. 5.30 mmol/l) among women. Geometric mean TG decreased by 14 % (1.66 mmol/l vs. 1.42 mmol/l) among men and by 8 % (1.20 mmol/l vs. 1.10 mmol/l) among women. Mean HDL-C remained unchanged among men (1.29 mmol/l vs. 1.27 mmol/l), but decreased by 5 % among women (1.66 mmol/l vs. 1.58 mmol/l). Sports activity and coffee consumption increased, while smoking and high alcohol consumption decreased only in men. Processed food consumption increased and wholegrain bread consumption decreased in both sexes, and obesity increased among men. The use of lipid-lowering medication, in particular statins nearly doubled over time in both sexes. Among women, hormonal contraceptive use increased and postmenopausal hormone therapy halved over time. The changes in lipid levels between surveys remained significant after adjusting for covariables. Serum TC and TG considerably declined over one decade in Germany, which can be partly explained by increased use of lipid-lowering medication and improved lifestyle among men. The decline in serum lipids among women, however, remains unexplained.